Advertisement

Infection

, Volume 40, Issue 6, pp 703–707 | Cite as

Rare pediatric rhino-orbital infection caused by Saksenaea vasiformis

  • S. J. Taj-AldeenEmail author
  • A. Falamarzi
  • A. AlMuzrkchi
  • J. Guarro
Case Report

Abstract

Rhinosinusitis infection due to Saksenaea vasiformis is extremely rare. The present case describes a rhino-orbital infection in a 21-month-old Chadian immunocompetent male child with a 2-month history of excessive tearing from the right eye, followed by swelling of the right upper and lower eye lids, associated with right facial swelling and dark coloration surrounding the lower eye lid. Coronal computed tomography (CT) scan of the paranasal sinuses showed opacification of the right nasal cavities with extension to the orbit. Non-septate fungal hyphae were diagnosed by tissue sections and a Blankophor P fluorescent stain microscopy. The culture grew zygomycetes, S. vasiformis that failed to sporulate on Sabouraud dextrose agar, the organism was sporulated after 1 week on Czapek agar medium, and produced flask-shaped brown pigmented sporangium with lateral rhizoids and hemispherical columella filled with spores. The patient underwent a right functional endoscopic sinus surgery, where debridement of both right maxillary and ethmoid sinuses was done. Treatment with amphotericin B lipid complex was started and continued for 41 days. The patient was clinically doing better with decreased eye and facial swelling, and his erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were decreased to normal values. The patient continued with treatment on posaconazole after his discharge, and his condition resolved without further sequelae. Rhinosinusitis due to mucormycosis should be considered in any patient, even in young children, presenting with progressive rhinosinusitis infection, whether immunocompromised or not. Early diagnosis may lead to a successful treatment and good prognosis.

Keywords

Rhino-orbital mucormycosis Saksenaea vasiformis Pediatric infection 

Notes

Conflict of interest

The authors report no conflicts of interest.

References

  1. 1.
    Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236–301.PubMedCrossRefGoogle Scholar
  2. 2.
    Ajello L, Dean DF, Irwin RS. The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis. Mycologia. 1976;68:52–62.PubMedCrossRefGoogle Scholar
  3. 3.
    Stewardson AJ, Holmes NE, Ellis DH, Howden BP. Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year-old immunocompetent woman. Mycoses. 2009;52:547–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Baradkar VP, Kumar S. Cutaneous zygomycosis due to Saksenaea vasiformis in an immunocompetent host. Indian J Dermatol. 2009;54:382–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Trotter DJ, Gonis G, Cottrill E, Coombs C. Disseminated Saksenaea vasiformis in an immunocompetent host. Med J Aust. 2008;189:519–20.PubMedGoogle Scholar
  6. 6.
    Solano T, Atkins B, Tambosis E, Mann S, Gottlieb T. Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adult. Clin Infect Dis. 2000;30:942–3.PubMedCrossRefGoogle Scholar
  7. 7.
    Baradkar VP, Mathur M, Taklikar S, Rathi M, Kumar S. Fatal rhino-orbito-cerebral infection caused by Saksenaea vasiformis in an immunocompetent individual: first case report from India. Indian J Med Microbiol. 2008;26:385–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Kompoti M, Michalia M, Kallitsi G, Giannopoulou P, Arabatzis M, Liapi G, Velegraki A, Trikka-Graphakos E, Clouva-Molyvdas PM. Fatal cutaneous Saksenaea vasiformis infection in a critically ill trauma patient. Mycoses. 2011;54:e599–601.PubMedCrossRefGoogle Scholar
  9. 9.
    Bearer EA, Nelson PR, Chowers MY, Davis CE. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient. J Clin Microbiol. 1994;32:1823–4.PubMedGoogle Scholar
  10. 10.
    Gonis G, Starr M. Fatal rhinoorbital mucormycosis caused by Saksenaea vasiformis in an immunocompromised child. Pediatr Infect Dis J. 1997;16:714–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Vega W, Orellana M, Zaror L, Gené J, Guarro J. Saksenaea vasiformis infections: case report and literature review. Mycopathologia. 2006;162:289–94.PubMedCrossRefGoogle Scholar
  12. 12.
    Alvarez E, Garcia-Hermoso D, Sutton DA, Cano JF, Stchigel AM, Hoinard D, Fothergill AW, Rinaldi MG, Dromer F, Guarro J. Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea. J Clin Microbiol. 2010;48:4410–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634–53.PubMedCrossRefGoogle Scholar
  14. 14.
    Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G; European Confederation of Medical Mycology Working Group on Zygomycosis. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011;17:1859–67.PubMedCrossRefGoogle Scholar
  15. 15.
    Kaushik R, Chander J, Gupta S, Sharma R, Punia RS. Fatal primary cutaneous zygomycosis caused by Saksenaea vasiformis: case report and review of literature. Surg Infect (Larchmt). 2012;13:125–9.CrossRefGoogle Scholar
  16. 16.
    Chander J, Kaur J, Attri A, Mohan H. Primary cutaneous zygomycosis from a tertiary care centre in north-west India. Indian J Med Res. 2010;131:765–70.PubMedGoogle Scholar
  17. 17.
    Wilson PA. Zygomycosis due to Saksenaea vasiformis caused by a magpie peck. Med J Aust. 2008;189:521–2.PubMedGoogle Scholar
  18. 18.
    Lechevalier P, Hermoso DG, Carol A, Bonacorsi S, Ferkdadji L, Fitoussi F, Lortholary O, Bourrillon A, Faye A, Dannaoui E, Angoulvant F. Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an immunocompetent adolescent. J Clin Microbiol. 2008;46:3169–72.PubMedCrossRefGoogle Scholar
  19. 19.
    Blanchet D, Dannaoui E, Fior A, Huber F, Couppié P, Salhab N, Hoinard D, Aznar C. Saksenaea vasiformis infection, French Guiana.. Emerg Infect Dis. 2008;14:342–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Padmaja IJ, Ramani TV, Kalyani S. Cutaneous zygomycosis: necrotising fascitis due to Saksenaea vasiformis. Indian J Med Microbiol. 2006;24:58–60.PubMedCrossRefGoogle Scholar
  21. 21.
    Vazquez L, Mateos JJ, Sanz-Rodriguez C, Perez E, Caballero D, San Miguel JF. Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B. Haematologica. 2005;90:ECR39.PubMedGoogle Scholar
  22. 22.
    Campelo C, de Miguel S, del Palacio A. Zigomicosis rinocerebral causada por Saksenaea vasiformis en un paciente diabetic. Enferm Infecc Microbiol Clin. 2005;23:77.Google Scholar
  23. 23.
    Kaufman L, Padhye AA, Parker S. Rhinocerebral zygomycosis caused by Saksenaea vasiformis. J Med Vet Mycol. 1988;26:237–41.PubMedCrossRefGoogle Scholar
  24. 24.
    Dehority W, Willert J, Pong A. Zygomycetes infections in pediatric hematology oncology patients: a case series and review of the literature. J Pediatr Hematol Oncol. 2009;31:911–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • S. J. Taj-Aldeen
    • 1
    Email author
  • A. Falamarzi
    • 2
  • A. AlMuzrkchi
    • 3
  • J. Guarro
    • 4
  1. 1.Mycology Unit, Microbiology Division, Department of Laboratory Medicine and PathologyHamad Medical CorporationDohaQatar
  2. 2.Pediatric Infectious Disease DivisionHamad Medical CorporationDohaQatar
  3. 3.Radiology DepartmentHamad Medical CorporationDohaQatar
  4. 4.Mycology UnitIISPV, Rovira i Virgili UniversityReusSpain

Personalised recommendations